Cargando…
Ruthenium Complex HB324 Induces Apoptosis via Mitochondrial Pathway with an Upregulation of Harakiri and Overcomes Cisplatin Resistance in Neuroblastoma Cells In Vitro
Ruthenium(II) complexes with N-heterocyclic carbene (NHC) ligands have recently attracted attention as novel chemotherapeutic agents. The complex HB324 was intensively studied as an apoptosis-inducing compound in resistant cell lines. HB324 induced apoptosis via mitochondrial pathways. Of particular...
Autores principales: | Wilke, Nicola L., Burmeister, Hilke, Frias, Corazon, Ott, Ingo, Prokop, Aram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866957/ https://www.ncbi.nlm.nih.gov/pubmed/36674465 http://dx.doi.org/10.3390/ijms24020952 |
Ejemplares similares
-
KP772 overcomes multiple drug resistance in malignant lymphoma and leukemia cells in vitro by inducing Bcl-2-independent apoptosis and upregulation of Harakiri
por: Kater, Lisa, et al.
Publicado: (2021) -
Evaluation of Ruthenium(II) N-Heterocyclic Carbene Complexes as Antibacterial Agents and Inhibitors of Bacterial Thioredoxin Reductase
por: Burmeister, Hilke, et al.
Publicado: (2021) -
Dihydroxyquingdainone Induces Apoptosis in Leukaemia and Lymphoma Cells via the Mitochondrial Pathway in a Bcl-2- and Caspase-3-Dependent Manner and Overcomes Resistance to Cytostatic Drugs In Vitro
por: Baas, Jennifer, et al.
Publicado: (2022) -
A metal-free salalen ligand with anti-tumor and synergistic activity in resistant leukemia and solid tumor cells via mitochondrial pathway
por: Hopff, Sina M., et al.
Publicado: (2021) -
Characterization of a Novel Interaction between Bcl-2 Members Diva and Harakiri
por: Sborgi, Lorenzo, et al.
Publicado: (2010)